Back to Search
DEEMPAL BHATT, PHARM.D
PHARM.D
Pharmacist
NPI: 1417393828Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
64882(CA)
Clinical Trials (1)
1
Linked Trials
0
Recruiting
1
With Results
Research & Publications (20)
Causes and Risk Factors for Death in Diabetes: A Competing-Risk Analysis From the SAVOR-TIMI 53 Trial.
PMID 33832610·J Am Coll Cardiol·2021
8-other
Heart Failure Risk Stratification and Efficacy of Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Type 2 Diabetes Mellitus.
PMID 31474116·Circulation·2019
4-observational
Metformin Use and Clinical Outcomes Among Patients With Diabetes Mellitus With or Without Heart Failure or Kidney Dysfunction: Observations From the SAVOR-TIMI 53 Trial.
PMID 31362530·Circulation·2019
3-trial
Cardiovascular Outcomes According to Urinary Albumin and Kidney Disease in Patients With Type 2 Diabetes at High Cardiovascular Risk: Observations From the SAVOR-TIMI 53 Trial.
PMID 29214305·JAMA Cardiol·2018
4-observational
DPP4 inhibitors and cardiovascular outcomes: safety on heart failure.
PMID 28417296·Heart Fail Rev·2017
6-review
Effect of Saxagliptin on Renal Outcomes in the SAVOR-TIMI 53 Trial.
PMID 27797925·Diabetes Care·2017
4-observational
Prognostic Implications of Biomarker Assessments in Patients With Type 2 Diabetes at High Cardiovascular Risk: A Secondary Analysis of a Randomized Clinical Trial.
PMID 27681000·JAMA Cardiol·2016
8-other
Cardiovascular Outcomes of Patients in SAVOR-TIMI 53 by Baseline Hemoglobin A1c.
PMID 26524706·Am J Med·2016
3-trial
Incidence of Fractures in Patients With Type 2 Diabetes in the SAVOR-TIMI 53 Trial.
PMID 26358285·Diabetes Care·2015
4-observational
Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes and moderate or severe renal impairment: observations from the SAVOR-TIMI 53 Trial.
PMID 25552421·Diabetes Care·2015
4-observational
Efficacy and safety of saxagliptin in older participants in the SAVOR-TIMI 53 trial.
PMID 25758769·Diabetes Care·2015
4-observational
Heart failure, saxagliptin, and diabetes mellitus: observations from the SAVOR-TIMI 53 randomized trial.
PMID 25189213·Circulation·2014
2-rct
Baseline characteristics of the patient population in the Saxagliptin Assessment of Vascular Outcomes Recorded in patients with diabetes mellitus (SAVOR)-TIMI 53 trial.
PMID 23564755·Diabetes Metab Res Rev·2013
4-observational
Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus.
PMID 23992601·N Engl J Med·2013
3-trial
The design and rationale of the saxagliptin assessment of vascular outcomes recorded in patients with diabetes mellitus-thrombolysis in myocardial infarction (SAVOR-TIMI) 53 study.
PMID 22093196·Am Heart J·2011
3-trial
Modulation of tricarboxylic acid cycle dehydrogenases during hepatocarcinogenesis induced by hexachlorocyclohexane in mice.
PMID 18951770·Exp Toxicol Pathol·2009
7-preclinical
Role of antiplatelet therapy across the spectrum of patients with coronary artery disease.
PMID 19166708·Am J Cardiol·2009
6-review
Platelet response in practice: Applying new insights and tools for testing and treatment.
PMID 19332591·Cleve Clin J Med·2009
5-case
Prior polyvascular disease: risk factor for adverse ischaemic outcomes in acute coronary syndromes.
PMID 19339264·Eur Heart J·2009
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3801 HOWE ST
OAKLAND, CA 94611 - Phone
- (510) 364-2357
Quick Facts
- NPI
- 1417393828
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Clinical Trials
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile